查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1542564

全球生物製藥合約製造市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Biopharmaceuticals Contract Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

全球生物製藥合約製造市場需求預計將從 2023 年的 197.4 億美元達到 2032 年近 339.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.2%。

生物製藥合約製造涉及將生物製藥產品的生產外包給專業合約製造商。這些產品包括單株抗體、疫苗和重組蛋白等生物製品，需要複雜的製造流程和嚴格的品質控制。合約製造組織 (CMO) 提供服務，包括細胞株開發、製程開發和大規模生產。這種模式允許生物製藥公司利用 CMO 的專業知識和能力，減少對內部生產設施和相關資本支出的需求。公司可以透過外包生產專注於研發，同時受益於 CMO 的先進技術和監管合規專業知識。

市場動態

由於對生物製劑和先進療法的需求不斷成長，生物製藥合約製造市場正在經歷強勁成長。生物製藥公司將製造業務外包給專業合約製造商，以擴大生產能力並滿足市場對單株抗體和基因療法等複雜生物藥物不斷成長的需求。生物製藥生產的高成本和複雜性推動了對合約製造服務的需求。合約製造商提供處理複雜生產流程和維持嚴格品質標準的專業知識，這對個別公司來說內部管理的成本過高。生物製藥公司可以減少資本投資和營運成本，同時透過外包獲得最先進的製造技術。

生物製造的技術進步正在市場中創造新的機會。一次性技術和連續製造流程等創新提高了生產效率和靈活性。這些進步可以縮短週轉時間並降低污染風險，使合約製造成為生物製藥公司有吸引力的選擇。個人化醫療的新興趨勢也促進了生物製藥合約製造市場的成長。小批量、高品質生產個人化治療藥物的需求非常適合合約製造商的能力。此外，生物技術行業的擴張和生物製藥研發投資的增加正在推動對合約製造服務的需求。然而，監管的複雜性和智慧財產權盜竊的風險可能會阻礙生物製藥合約製造市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球生物製藥合約製造市場的每個細分市場進行了包容性評估。生物製藥合約製造業的成長和趨勢為本研究提供了整體方法。

市場區隔

生物製藥合約製造市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按來源

  • 哺乳動物
  • 非哺乳動物

按服務

  • 製程開發（下游、上游）
  • 填充和完成操作
  • 分析和品質控制研究
  • 包裝

按產品分類

  • 生物製劑（單株抗體 (MAB)、重組蛋白、疫苗、反義、RNAi 和分子療法等）
  • 生物相似藥
  • 區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲生物製藥合約製造市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。生物製藥合約製造市場的主要參與者包括 Boehringer Ingelheim GmbH、Lonza、Inno Biologics Sdn Bhd、Rentschler Biotechnologie GmbH、JRS Pharma、AGC Biologics、ProBioGen、Fujifilm Diosynth Biotechnologies USA, Inc.、Toyobo Co., Ltd. 、Thermo Fisher Scientific, Inc.、Binex Co., Ltd.、WuXi Biologics、AbbVie, Inc.。概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：生物製藥合約製造 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按來源
    • 按服務
    • 按產品分類
    • ：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

  • Covid-19 爆發的影響分析
    • 對生產的直接影響
    • 供應鍊和市場顛覆
    • 對公司和金融市場的財務影響
  • 按生產、進口、出口和需求分類的 COVID-19 影響分析
  • 市場：COVID-19 之前/之後
  • 冠狀病毒 (COVID-19) 疫情的預期影響
  • COVID-19：微觀和宏觀因素分析

第 6 章：全球生物製藥合約製造市場分析：依來源分類

  • 按來源概述
  • 歷史和預測數據
  • 按來源分析
  • 哺乳動物市場：按地區
  • 非哺乳類市場：按地區

第 7 章：全球生物製藥合約製造市場分析：按服務分類

  • 按服務概覽
  • 歷史和預測數據
  • 按服務分析
  • 製程開發市場：按地區
  • 填充和完成操作市場：按地區
  • 分析和品質控制研究市場：按地區
  • 包裝市場：按地區

第 8 章：全球生物製藥合約製造市場分析：依產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 生物製品市場：按地區
  • 生物相似藥市場：按地區

第 9 章：全球生物製藥合約製造市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美洲
    • 概覽、歷史和預測數據
    • 北美按細分市場
    • 北美洲：依國家分類
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 概覽、歷史和預測數據
    • 歐洲按細分市場
    • 歐洲 : 按國家/地區
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 概覽、歷史和預測數據
    • 亞太地區（按細分市場）
    • 亞太地區：依國家分類
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 拉丁美洲
    • 概覽、歷史和預測數據
    • 拉丁美洲按細分市場
    • 拉丁美洲 : 依國家分類
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概覽、歷史和預測數據
    • 中東和非洲細分市場
    • 中東和非洲：按國家/地區
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 中東和非洲其他地區

第 10 章：生物製藥合約製造公司的競爭格局

  • 生物製藥合約製造市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Boehringer Ingelheim GmbH
    • 公司概況
    • 產品
    • 最新動態
  • Lonza
    • 公司概況
    • 產品
    • 最新動態
  • Inno Biologics Sdn Bhd
    • 公司概況
    • 產品
    • 最新動態
  • Rentschler Biotechnologie GmbH
    • 公司概況
    • 產品
    • 最新動態
  • JRS Pharma
    • 公司概況
    • 產品
    • 最新動態
  • AGC Biologics
    • 公司概況
    • 產品
    • 最新動態
  • ProBioGen
    • 公司概況
    • 產品
    • 最新動態
  • Fujifilm Diosynth Biotechnologies USA, Inc.
    • 公司概況
    • 產品
    • 最新動態
  • Toyobo Co., Ltd.
    • 公司概況
    • 產品
    • 最新動態
  • Samsung BioLogics
    • 公司概況
    • 產品
    • 最新動態
  • Thermo Fisher Scientific, Inc.
    • 公司概況
    • 產品
    • 最新動態
  • Binex Co., Ltd.
    • 公司概況
    • 產品
    • 最新動態
  • WuXi Biologics
    • 公司概況
    • 產品
    • 最新動態
  • AbbVie, Inc.
    • 公司概況
    • 產品
    • 最新動態

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11214545

The global demand for Biopharmaceuticals Contract Manufacturing Market is presumed to reach the market size of nearly USD 33.92 Billion by 2032 from USD 19.74 Billion in 2023 with a CAGR of 6.2% under the study period 2024 - 2032.

Biopharmaceuticals contract manufacturing involves outsourcing the production of biopharmaceutical products to specialized contract manufacturers. These products include biologics such as monoclonal antibodies, vaccines, and recombinant proteins, which require complex manufacturing processes and stringent quality control. Contract manufacturing organizations (CMOs) provide services, including cell line development, process development, and large-scale production. This model allows biopharmaceutical companies to leverage the expertise and capabilities of CMOs, reducing the need for in-house manufacturing facilities and associated capital expenditures. Companies can focus on research and development by outsourcing production while benefiting from the CMOs' advanced technologies and regulatory compliance expertise.

Market Dynamics

The biopharmaceuticals contract manufacturing market is experiencing robust growth attributed to the rising demand for biologics & advanced therapeutics. Biopharmaceutical companies outsource manufacturing to specialized contract manufacturers to scale production capabilities and meet the growing market demand for complex biologic drugs, such as monoclonal antibodies and gene therapies. Biopharmaceutical production's high cost and complexity drive the need for contract manufacturing services. Contract manufacturers offer expertise in handling sophisticated production processes and maintaining stringent quality standards, which can be cost-prohibitive for individual companies to manage in-house. Biopharmaceutical firms can reduce capital investments and operational costs while accessing state-of-the-art manufacturing technologies by outsourcing.

Technological advancements in bio-manufacturing are creating new opportunities within the market. Innovations such as single-use technologies and continuous manufacturing processes enhance production efficiency and flexibility. These advancements enable faster turnaround times and reduced risk of contamination, making contract manufacturing an attractive option for biopharmaceutical companies. The emerging trend of personalized medicine is also contributing to the growth of the biopharmaceuticals contract manufacturing market. The need for small-batch, high-quality production of personalized therapeutics is well-suited to contract manufacturers' capabilities. Additionally, the expansion of the biotechnology sector and increasing investments in biopharmaceutical R&D are driving demand for contract manufacturing services. However, regulatory complexities and the risk of intellectual property theft may hinder biopharmaceuticals contract manufacturing market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biopharmaceuticals contract manufacturing. The growth and trends of biopharmaceuticals contract manufacturing industry provide a holistic approach to this study.

Market Segmentation

This section of the biopharmaceuticals contract manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Source

  • Mammalian
  • Non-mammalian

By Service

  • Process Development (Downstream, Upstream)
  • Fill & Finish Operations
  • Analytical & QC Studies
  • Packaging

By Product

  • Biologics (Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, & Molecular Therapy, Others)
  • Biosimilars
  • Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Biopharmaceuticals Contract Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biopharmaceuticals contract manufacturing market include Boehringer Ingelheim GmbH, Lonza, Inno Biologics Sdn Bhd, Rentschler Biotechnologie GmbH, JRS Pharma, AGC Biologics, ProBioGen, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Toyobo Co., Ltd., Samsung BioLogics, Thermo Fisher Scientific, Inc., Binex Co., Ltd., WuXi Biologics, AbbVie, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BIOPHARMACEUTICALS CONTRACT MANUFACTURING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Source
    • 3.7.2 By Service
    • 3.7.3 By Product
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY SOURCE

  • 6.1 Overview by Source
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Source
  • 6.4 Mammalian Market by Regions
  • 6.5 Non-mammalian Market by Regions

7 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY SERVICE

  • 7.1 Overview by Service
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Service
  • 7.4 Process Development Market by Regions
  • 7.5 Fill & Finish Operations Market by Regions
  • 7.6 Analytical & QC Studies Market by Regions
  • 7.7 Packaging Market by Regions

8 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY PRODUCT

  • 8.1 Overview by Product
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Product
  • 8.4 Biologics Market by Regions
  • 8.5 Biosimilars Market by Regions

9 . GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE BIOPHARMACEUTICALS CONTRACT MANUFACTURING COMPANIES

  • 10.1. Biopharmaceuticals Contract Manufacturing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF BIOPHARMACEUTICALS CONTRACT MANUFACTURING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Boehringer Ingelheim GmbH
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Lonza
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Inno Biologics Sdn Bhd
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Rentschler Biotechnologie GmbH
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. JRS Pharma
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. AGC Biologics
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. ProBioGen
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Toyobo Co., Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Samsung BioLogics
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Thermo Fisher Scientific, Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Binex Co., Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financials
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. WuXi Biologics
    • 11.15.1. Company Overview
    • 11.15.2. Financials
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. AbbVie, Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financials
    • 11.16.3. Products
    • 11.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Source (USD MN)
  • Mammalian Market by Geography (USD MN)
  • Non-mammalian Market by Geography (USD MN)
  • Analysis Market by Service (USD MN)
  • Process Development Market by Geography (USD MN)
  • Fill & Finish Operations Market by Geography (USD MN)
  • Analytical & QC Studies Market by Geography (USD MN)
  • Packaging Market by Geography (USD MN)
  • Analysis by Product (USD MN)
  • Biologics Market by Geography (USD MN)
  • Biosimilars Market by Geography (USD MN)
  • Global Biopharmaceuticals Contract Manufacturing Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biopharmaceuticals Contract Manufacturing Report
  • Market Research Process
  • Market Research Methodology
  • Global Biopharmaceuticals Contract Manufacturing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Source
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Source (USD MN)
  • Mammalian Market by Geography (USD MN)
  • Non-mammalian Market by Geography (USD MN)
  • Global Market Analysis by Service (USD MN)
  • Process Development Market by Geography (USD MN)
  • Fill & Finish Operations Market by Geography (USD MN)
  • Analytical & QC Studies Market by Geography (USD MN)
  • Packaging Market by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Biologics Market by Geography (USD MN)
  • Biosimilars Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.